
DINGDANG HEALTH (9886) expects its net loss for the last fiscal year to narrow by more than 80% year-on-year

I'm LongbridgeAI, I can summarize articles.
DINGDANG HEALTH expects that the annual net loss for the year ending December 31, 2025, will significantly narrow by over 80% compared to approximately RMB 380 million for the fiscal year 2024. The reasons for the improvement include: a significant reduction in goodwill impairment losses accrued in the fiscal year 2024, continuous optimization of urban layout strategies, focusing on core first-tier cities, expanding the smart pharmacy network, and strengthening supply chain service capabilities while optimizing the product sales mix to enhance overall operational efficiency and profitability
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

